A photo of Cuixia Tian.

Neuromuscular Disease Specialist, Division of Neurology

Assistant Professor, UC Department of Pediatrics

513-636-4222

Board Certified

About Me

Biography

Dr. Tian received her MD from the Medical Center of Fudan in 1993, and continued on there as a resident and chief resident until 1998.

From 1999-2003, she was a research fellow in the Department of Medicine at Vanderbilt University focusing on hematology and oncology.

Dr. Tian then became a research fellow from 2003-2008 at Vanderbilt in the Department of Pediatrics focusing on pediatric infectious disease.

In 2009, Dr. Tian became a pediatrics and neurology resident at Cincinnati Children’s Hospital Medical Center.

Additional Languages

Chinese

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Departments

Neurology, Neuromuscular Disorders

My Locations

My Education

MD: Medical Center of Fudan University, Shanghai, China, 1993.

Residency: Cincinnati Children’s Hospital Medical Center.

Myology Institute Clinical Myology Training; Paris, France, 2014.

Wellstone Myology Training; Ohio State University, Columbus, OH, 2013.

World Muscle Society Satellite Training; Asilomar, California, 2013.

My Publications

Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naive Patients with Duchenne Muscular Dystrophy. Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al. The Journal of Pediatrics. 2019; 210:194-200.e2.

White Matter Lesions Detected by Magnetic Resonance Imaging in Neonates and Children With Congenital Myotonic Dystrophy. Peglar, LM; Nagaraj, UD; Tian, C; Venkatesan, C. Pediatric Neurology. 2019; 96:64-69.

Consensus-based care recommendations for adults with myotonic dystrophy type 1. Ashizawa, T; Gagnon, C; Groh, WJ; Gutmann, L; Johnson, NE; Meola, G; Moxley, R; Pandya, S; Rogers, MT; Simpson, E; et al. Neurology: Clinical Practice. 2018; 8:507-520.

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. Wong, BL; Rybalsky, I; Shellenbarger, KC; Tian, C; McMahon, MA; Rutter, MM; Sawnani, H; Jefferies, JL. The Journal of Pediatrics. 2017; 182:296-303.e1.

Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Miller, L; Bange, J; Rybalsky, I; Rutter, MM. Neuromuscular Disorders. 2016; 26:760-767.